Buy 5-MeO-MIPT Powder

7 views

Skip to first unread message

Research Chem updates

unread,

Feb 11, 2026, 9:12:45 PMFeb 11

to cornerstone platform

Buy 5-MeO-MIPT Powder
Buy 5-MeO-MIPT Powder (known by the street name Moxy or Moxie) is a psychedelic and hallucinogenic drug, used by some as an entheogen. It has structural and pharmacodynamic properties similar to the drugs 5-MeO-DiPT, DiPT, and MiPT. It is commonly used as a “substitute” for 5-MeO-DiPT because of the very similar structure and effects. This certified solution standard is suitable for Moxy testing methods by GC/MS or LC/MS testing applications in clinical toxicology, urine drug testing, or forensic analysis. The use of 5-MeO-MiPT has recently been reported in Europe.

Chemistry
5-MeO-MiPT is in a class of compounds commonly known as tryptamines, and is the N-methyl-N-isopropyl homologue of the psychedelic, 5-MeO-DMT. The full name of the chemical is 5-methoxy-N-methyl-N-isopropyltryptamine.

5-MeO-MiPT causes the ehrlich reagent to turn purple then fade to faint blue. It causes the marquis reagent to go yellow through to black.

Dosage
Orally, 5-MeO-MiPT is active at 4-6 mg. The drug can also be smoked, but unlike most other tryptamines, this route requires a much higher dosage. 10–20 mg is usually smoked. It typically produces a very strong odor.

Some users report activity as low as 1 mg while others report no activity up to 20 mg, this compound seems to be highly sensitive to the individual and any potential researchers should keep this in mind. Titrating the dose would be especially important with this compound.

Some users report little to no visual activity until doses of 10 mg or higher are taken. This chemical proves very useful for opening up and expressing oneself much like MDMA (3,4-methylenedioxymethamphetamine) and may be a useful chemical in psychedelic therapy.

Pharmacology
The mechanism that produces the hallucinogenic and entheogenic effects of 5-MeO-MiPT is thought to result primarily from 5-HT2A receptor agonism, although additional mechanisms of action such as inhibition of MAO may be involved also. 5-MeO-MiPT binds most strongly to 5-HT1A receptors; it also shows fairly strong binding affinity to the SERT and NET, thereby acting as a moderately potent serotonin-norepinephrine reuptake inhibitor. These mechanisms may help explain why there are many anecdotal reports of anti-depressant and anxiolytic effects from modest doses of this compound. For example, SNRIs such as venlafaxine are commonly prescribed to treat depression, and the 5-HT1A agonist buspirone is prescribed primarily for treatment of anxiety.

Chemical and physical data
Formula: C15H22N2O

Molar mass: 246.35 g/mol g·mol?1

See also
MIPT
5-MeO-DMT
5-MeO-DiPT

https://alpharesearchlab.net/product/buy-5-meo-mipt-powder/

Buy BK-EBDP Powder

CAS: ‎727641-67-0
Formula: C14H19NO3
Purity: 99,7% min
Molecular weight: 249.310
Appearance: Powder
Synonyms: BK-EBDP, N-Ethylpentylone, BK-Ethyl-K

https://alpharesearchlab.net/product/buy-bk-ebdp-powder/

Buy 4-MeO-PCP CRYSTAL
Buy 4-MeO-PCP CRYSTAL 4-Methoxyphencyclidine (methoxydine, 4-MeO-PCP) is a dissociative anesthetic drug that has been sold online as a research chemical. The synthesis of 4-MeO-PCP was first reported in 1965 by the Parke-Davis medicinal chemist Victor Maddox. A 1999 review published by a chemist using the pseudonym John Q. Beagle suggested the potency of 4-MeO-PCP in man was reduced relative to PCP, two years later Beagle published a detailed description of the synthesis and qualitative effects of 4-MeO-PCP, which he said possessed 70% the potency of PCP. 4-MeO-PCP was the first arylcyclohexylamine research chemical to be sold online, it was introduced in late 2008 by a company trading under the name CBAY and was followed by several related compounds such as 3-MeO-PCP and methoxetamine.

4-MeO-PCP has lower affinity for the NMDA receptor than PCP, but higher affinity than ketamine, it is orally active in a dosage range similar to ketamine, with some users requiring doses in excess of 100 mg for desired effects. Users have reported substantial differences in active dose, these discrepancies can be partially explained by the presence of unreacted PCC and other impurities in samples sold on the grey market. 4-MeO-PCP has Ki values of 404 nM for the NMDA receptor, 713 nM for the norepinephrine transporter, 844 nM for the serotonin transporter, 296 nM for the ?1 receptor and 143 nM for the ?2 receptor.

4-MeO-PCP hydrochloride is a white crystalline solid with a melting point of 181-182 °C

Shipping & Storage Information
Storage: -20°C

Shipping: Room Temperature in continental US; may vary elsewhere

Stability: ? 2 years

Technical Information
Formal Name: 1-[1-(4-methoxyphenyl)cyclohexyl]-piperidine, monohydrochloride
CAS Number: 2185-93-5
Purity: ?98%
Formulation: A crystalline solid
?max: 231, 272 nm
SMILES: COC(C=C1)=CC=C1C2(N3CCCCC3)CCCCC2.Cl
InChi CodeInChI=1S/C18H27NO.ClH/c1-20-17-10-8-16(9-11-17)18(12-4-2-5-13-18)19-14-6-3-7-15-19;/h8-11H,2-7,12-15H2,1H3;1H
InChi Key: FYAFJNVLHWQLHK-UHFFFAOYSA-N
Side effects
4-MeO-PCP has caused a fatality in combination with 4-HO-MET, venlafaxine, olanzapine, lorazepam and hydroxyzine.

Chemical and physical
Formula: C18H27NO

Molar mass: 273.420 g·mol?1

See also
Arylcyclohexylamine
3-HO-PCP
3-MeO-PCE
3-MeO-PCMo
3-MeO-PCP
Methoxetamine
Methoxyketamine